Decoding telomere protein Rap1: Its telomeric and nontelomeric functions and potential implications in diabetic cardiomyopathy

References

• de Lange T. Protection of mammalian telomeres. Oncogene. 2002;21:532-40. doi:10.1038/sj.onc.1205080. PMID:11850778
   PubMed Web of Science ®Google Scholar
• de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2005;19:2100-10. doi:10.1101/gad.1346005. PMID:16166375
   PubMed Web of Science ®Google Scholar
• Palm W, de Lange T. How shelterin protects mammalian telomeres. Annu Rev Genet. 2008;42:301-34. doi:10.1146/annurev.genet.41.110306.130350. PMID:18680434
   PubMed Web of Science ®Google Scholar
• Shore D, Nasmyth K. Purification and cloning of a DNA binding protein from yeast that binds to both silencer and activator elements. Cell. 1987;51:721-32. doi:10.1016/0092-8674(87)90095-X. PMID:3315231
   PubMed Web of Science ®Google Scholar
• Konig P, Giraldo R, Chapman L, Rhodes D. The crystal structure of the DNA-binding domain of yeast RAP1 in complex with telomeric DNA. Cell. 1996;85:125-36. doi:10.1016/S0092-8674(00)81088-0. PMID:8620531
   PubMed Web of Science ®Google Scholar
• Li B, Oestreich S, de Lange T. Identification of human Rap1: implications for telomere evolution. Cell. 2000;101:471-83. doi:10.1016/S0092-8674(00)80858-2. PMID:10850490
   PubMed Web of Science ®Google Scholar
• Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol. 1992;225:951-60. doi:10.1016/0022-2836(92)90096-3. PMID:1613801
   PubMed Web of Science ®Google Scholar
• Brouilette S, Singh RK, Thompson JR, Goodall AH, Samani NJ. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol. 2003;23:842-6. doi:10.1161/01.ATV.0000067426.96344.32. PMID:12649083
   PubMed Web of Science ®Google Scholar
• Benetos A, Gardner JP, Zureik M, Labat C, Xiaobin L, Adamopoulos C, Temmar M, Bean KE, Thomas F, Aviv A. Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension. 2004;43:182-5. doi:10.1161/01.HYP.0000113081.42868.f4. PMID:14732735
   PubMed Web of Science ®Google Scholar
• Shay JW, Wright WE. Role of telomeres and telomerase in cancer. Semin Cancer Biol. 2011;21:349-53. doi:10.1016/j.semcancer.2011.10.001. PMID:22015685
   PubMed Web of Science ®Google Scholar
• Grunstein M. Molecular model for telomeric heterochromatin in yeast. Curr Opin Cell Biol. 1997;9:383-7. doi:10.1016/S0955-0674(97)80011-7. PMID:9159071
   PubMed Web of Science ®Google Scholar
• Kaizer H, Connelly CJ, Bettridge K, Viggiani C, Greider CW. Regulation of Telomere Length Requires a Conserved N-Terminal Domain of Rif2 in Saccharomyces cerevisiae. Genetics. 2015;201:573-86. doi:10.1534/genetics.115.177899. PMID:26294668
   PubMed Web of Science ®Google Scholar
• Moretti P, Freeman K, Coodly L, Shore D. Evidence that a complex of SIR proteins interacts with the silencer and telomere-binding protein RAP1. Genes Dev. 1994;8:2257-69. doi:10.1101/gad.8.19.2257. PMID:7958893
   PubMed Web of Science ®Google Scholar
• van Steensel B, de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature. 1997;385:740-3. doi:10.1038/385740a0. PMID:9034193
   PubMed Web of Science ®Google Scholar
• O'Connor MS, Safari A, Liu D, Qin J, Songyang Z. The human Rap1 protein complex and modulation of telomere length. J Biol Chem. 2004;279:28585-91. doi:10.1074/jbc.M312913200. PMID:15100233
   PubMed Web of Science ®Google Scholar
• Li B, de Lange T. Rap1 affects the length and heterogeneity of human telomeres. Mol Biol Cell. 2003;14:5060-8. doi:10.1091/mbc.E03-06-0403. PMID:14565979
   PubMed Web of Science ®Google Scholar
• Kabir S, Hockemeyer D, de Lange T. TALEN gene knockouts reveal no requirement for the conserved human shelterin protein Rap1 in telomere protection and length regulation. Cell Reports. 2014;9:1273-80. doi:10.1016/j.celrep.2014.10.014. PMID:25453752
   PubMed Web of Science ®Google Scholar
• Sfeir A, Kabir S, van Overbeek M, Celli GB, de Lange T. Loss of Rap1 induces telomere recombination in the absence of NHEJ or a DNA damage signal. Science. 2010;327:1657-61. doi:10.1126/science.1185100. PMID:20339076
   PubMed Web of Science ®Google Scholar
• Martinez P, Gomez-Lopez G, Garcia F, Mercken E, Mitchell S, Flores JM, de Cabo R, Blasco MA. RAP1 protects from obesity through its extratelomeric role regulating gene expression. Cell Reports. 2013;3:2059-74. doi:10.1016/j.celrep.2013.05.030. PMID:23791526
   PubMed Web of Science ®Google Scholar
• Lu W, Zhang Y, Liu D, Songyang Z, Wan M. Telomeres-structure, function, and regulation. Exp Cell Res. 2013;319:133-41. doi:10.1016/j.yexcr.2012.09.005. PMID:23006819
   PubMed Web of Science ®Google Scholar
• Celli GB, de Lange T. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat Cell Biol. 2005;7:712-8. doi:10.1038/ncb1275. PMID:15968270
   PubMed Web of Science ®Google Scholar
• van Steensel B, Smogorzewska A, de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell. 1998;92:401-13. doi:10.1016/S0092-8674(00)80932-0. PMID:9476899
   PubMed Web of Science ®Google Scholar
• Celli GB, Denchi EL, de Lange T. Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nat Cell Biol. 2006;8:885-90. doi:10.1038/ncb1444. PMID:16845382
   PubMed Web of Science ®Google Scholar
• Rai R, Chen Y, Lei M, Chang S. TRF2-RAP1 is required to protect telomeres from engaging in homologous recombination-mediated deletions and fusions. Nat Commun. 2016;7:10881. doi:10.1038/ncomms10881. PMID:26941064
   PubMed Web of Science ®Google Scholar
• Chen Y, Rai R, Zhou ZR, Kanoh J, Ribeyre C, Yang Y, Zheng H, Damay P, Wang F, Tsujii H, et al. A conserved motif within RAP1 has diversified roles in telomere protection and regulation in different organisms. Nat Structural Mol Biol. 2011;18:213-21. doi:10.1038/nsmb.1974.
   PubMed Web of Science ®Google Scholar
• Hegan DC, Lu Y, Stachelek GC, Crosby ME, Bindra RS, Glazer PM. Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130. Proc Natl Acad Sci U S A. 2010;107:2201-6. doi:10.1073/pnas.0904783107. PMID:20133863
   PubMed Web of Science ®Google Scholar
• Azad GK, Tomar RS. The multifunctional transcription factor Rap1: a regulator of yeast physiology. Frontiers Biosci (Landmark edition). 2016;21:918-30. doi:10.2741/4429.
   PubMed Web of Science ®Google Scholar
• Martinez P, Thanasoula M, Carlos AR, Gomez-Lopez G, Tejera AM, Schoeftner S, Dominguez O, Pisano DG, Tarsounas M, Blasco MA. Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites. Nat Cell Biol. 2010;12:768-80. doi:10.1038/ncb2081. PMID:20622869
   PubMed Web of Science ®Google Scholar
• Hanaoka S, Nagadoi A, Yoshimura S, Aimoto S, Li B, de Lange T, Nishimura Y. NMR structure of the hRap1 Myb motif reveals a canonical three-helix bundle lacking the positive surface charge typical of Myb DNA-binding domains. J Mol Biol. 2001;312:167-75. doi:10.1006/jmbi.2001.4924. PMID:11545594
   PubMed Web of Science ®Google Scholar
• Janoušková E, Nečasová I, Pavloušková J, Zimmermann M, Hluchý M, Marini V, Nováková M, Hofr C. Human Rap1 modulates TRF2 attraction to telomeric DNA. Nucleic Acids Res. 2015;43:2691-700. doi:10.1093/nar/gkv097. PMID:25675958
   PubMed Web of Science ®Google Scholar
• Khan S, Chuturgoon AA, Naidoo DP. Telomeres and atherosclerosis. Cardiovascular J Africa. 2012;23:563-71. doi:10.5830/CVJA-2012-056.
   PubMed Web of Science ®Google Scholar
• Armanios M. Telomeres and age-related disease: how telomere biology informs clinical paradigms. J Clin Invest. 2013;123:996-1002. doi:10.1172/JCI66370. PMID:23454763
   PubMed Web of Science ®Google Scholar
• Eisele PS, Salatino S, Sobek J, Hottiger MO, Handschin C. The peroxisome proliferator-activated receptor gamma coactivator 1alpha/beta (PGC-1) coactivators repress the transcriptional activity of NF-kappaB in skeletal muscle cells. J Biol Chem. 2013;288:2246-60. doi:10.1074/jbc.M112.375253. PMID:23223635
   PubMed Web of Science ®Google Scholar
• Patten IS, Arany Z. PGC-1 coactivators in the cardiovascular system. Trends Endocrinol Metab TEM. 2012;23:90-7. doi:10.1016/j.tem.2011.09.007. PMID:22047951
   PubMed Web of Science ®Google Scholar
• Sahin E, Colla S, Liesa M, Moslehi J, Muller FL, Guo M, Cooper M, Kotton D, Fabian AJ, Walkey C, et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 2011;470:359-65. doi:10.1038/nature09787. PMID:21307849
   PubMed Web of Science ®Google Scholar
• Hardy CF, Sussel L, Shore D. A RAP1-interacting protein involved in transcriptional silencing and telomere length regulation. Genes Dev. 1992;6:801-14. doi:10.1101/gad.6.5.801. PMID:1577274
   PubMed Web of Science ®Google Scholar
• O'Connor MS, Safari A, Liu D, Qin J, Songyang Z. The human Rap1 protein complex and modulation of telomere length. J Biol Chem. 2004;279:28585-91. doi:10.1074/jbc.M312913200. PMID:15100233
   PubMed Web of Science ®Google Scholar
• Shore D. RAP1: a protean regulator in yeast. Trends Genet. 1994;10:408-12. doi:10.1016/0168-9525(94)90058-2. PMID:7809947
   PubMed Web of Science ®Google Scholar
• Chambers A, Stanway C, Tsang JS, Henry Y, Kingsman AJ, Kingsman SM. ARS binding factor 1 binds adjacent to RAP1 at the UASs of the yeast glycolytic genes PGK and PYK1. Nucleic Acids Res. 1990;18:5393-9. doi:10.1093/nar/18.18.5393. PMID:2120676
   PubMed Web of Science ®Google Scholar
• Nishizawa M, Araki R, Teranishi Y. Identification of an upstream activating sequence and an upstream repressible sequence of the pyruvate kinase gene of the yeast Saccharomyces cerevisiae. Mol Cell Biol. 1989;9:442-51. doi:10.1128/MCB.9.2.442. PMID:2651900
   PubMed Web of Science ®Google Scholar
• Butler G, Dawes IW, McConnell DJ. TUF factor binds to the upstream region of the pyruvate decarboxylase structural gene (PDC1) of Saccharomyces cerevisiae. Mol Gen Genet. 1990;223:449-56. doi:10.1007/BF00264453. PMID:2270085
   PubMedGoogle Scholar
• Bitter GA, Chang KK, Egan KM. A multi-component upstream activation sequence of the Saccharomyces cerevisiae glyceraldehyde-3-phosphate dehydrogenase gene promoter. Mol Gen Genet. 1991;231:22-32. doi:10.1007/BF00293817. PMID:1753943
   PubMedGoogle Scholar
• Yeung F, Ramirez CM, Mateos-Gomez PA, Pinzaru A, Ceccarini G, Kabir S, Fernandez-Hernando C, Sfeir A. Nontelomeric role for Rap1 in regulating metabolism and protecting against obesity. Cell Reports. 2013;3:1847-56. doi:10.1016/j.celrep.2013.05.032. PMID:23791522
   PubMed Web of Science ®Google Scholar
• Leone TC, Weinheimer CJ, Kelly DP. A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A. 1999;96:7473-8. doi:10.1073/pnas.96.13.7473. PMID:10377439
   PubMed Web of Science ®Google Scholar
• Costet P, Legendre C, Moré J, Edgar A, Galtier P, Pineau T. Peroxisome proliferator-activated receptor α-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem. 1998;273:29577-85. doi:10.1074/jbc.273.45.29577. PMID:9792666
   PubMed Web of Science ®Google Scholar
• Qatanani M, Lazar MA. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 2007;21:1443-55. doi:10.1101/gad.1550907. PMID:17575046
   PubMed Web of Science ®Google Scholar
• Lawrence T. The Nuclear Factor NF-κB pathway in inflammation. Cold Spring Harbor Perspect Biol. 2009;1:a001651. doi:10.1101/cshperspect.a001651.
   PubMed Web of Science ®Google Scholar
• Teo H, Ghosh S, Luesch H, Ghosh A, Wong ET, Malik N, Orth A, de Jesus P, Perry AS, Oliver JD, et al. Telomere-independent Rap1 is an IKK adaptor and regulates NF-kappaB-dependent gene expression. Nat Cell Biol. 2010;12:758-67. doi:10.1038/ncb2080. PMID:20622870
   PubMed Web of Science ®Google Scholar
• Ghosh AS, Tergaonkar V. Telomeres and inflammation: Rap1 joins the ends? Cell cycle (Georgetown, Tex). 2010;9:3834-5. doi:10.4161/cc.9.19.13383. PMID:20890110
   PubMed Web of Science ®Google Scholar
• Ghosh A, Saginc G, Leow SC, Khattar E, Shin EM, Yan TD, Wong M, Zhang Z, Li G, Sung WK, et al. Telomerase directly regulates NF-kappaB-dependent transcription. Nat Cell Biol. 2012;14:1270-81. doi:10.1038/ncb2621. PMID:23159929
   PubMed Web of Science ®Google Scholar
• Cai Y, Sukhova GK, Wong HK, Xu A, Tergaonkar V, Vanhoutte PM, Tang EHC. Rap1 induces cytokine production in pro-inflammatory macrophages through NFκB signaling and is highly expressed in human atherosclerotic lesions. Cell Cycle (Georgetown, Tex). 2015;14:3580-92. doi:10.1080/15384101.2015.1100771. PMID:26505215
   PubMed Web of Science ®Google Scholar
• Takai KK, Hooper S, Blackwood S, Gandhi R, de Lange T. In vivo stoichiometry of shelterin components. J Biol Chem. 2010;285:1457-67. doi:10.1074/jbc.M109.038026. PMID:19864690
   PubMed Web of Science ®Google Scholar
• Poon MW, Yan L, Jiang D, Qin P, Tse HF, Wong IY, Wong DS, Tergaonkar V, Lian Q. Inhibition of RAP1 enhances corneal recovery following alkali injury. Invest Ophthalmol Visual Sci. 2015;56:711-21. doi:10.1167/iovs.14-15268.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chiu S, Liang X, Gao F, Zhang Z, Liao S, Liang Y, Chai YH, Low DJH, Tse HF, et al. Rap1-mediated nuclear factor-kappaB (NF-κB) activity regulates the paracrine capacity of mesenchymal stem cells in heart repair following infarction. Cell Death Discovery. 2015;1:15007. doi:10.1038/cddiscovery.2015.7. PMID:27551443
   PubMedGoogle Scholar
• Li CX, Lo CM, Lian Q, Ng KT, Liu XB, Ma YY, Qi X, Yeung OW, Tergaonkar V, Yang XX, et al. Repressor and activator protein accelerates hepatic ischemia reperfusion injury by promoting neutrophil inflammatory response. Oncotarget. 2016;7:27711-23. doi:10.18632/oncotarget.8509. PMID:27050284
   PubMed Web of Science ®Google Scholar
• Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 1998;16:225-60. doi:10.1146/annurev.immunol.16.1.225. PMID:9597130
   PubMed Web of Science ®Google Scholar
• Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006;86:515-81. doi:10.1152/physrev.00024.2005. PMID:16601268
   PubMed Web of Science ®Google Scholar
• Monaco C, Paleolog E. Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis. Cardiovasc Res. 2004;61:671-82. doi:10.1016/j.cardiores.2003.11.038. PMID:14985064
   PubMed Web of Science ®Google Scholar
• Mallat Z, Tedgui A. NF-κB activation in atherosclerosis: a friend or a foe? Blood. 2004;103:754-5. doi:10.1182/blood-2003-11-3818.
   Web of Science ®Google Scholar
• Kanters E, Pasparakis M, Gijbels MJ, Vergouwe MN, Partouns-Hendriks I, Fijneman RJ, Clausen BE, Forster I, Kockx MM, Rajewsky K, et al. Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest. 2003;112:1176-85. doi:10.1172/JCI200318580. PMID:14561702
   PubMed Web of Science ®Google Scholar
• Xanthoulea S, Curfs DM, Hofker MH, de Winther MP. Nuclear factor kappa B signaling in macrophage function and atherogenesis. Curr Opin Lipidol. 2005;16:536-42. doi:10.1097/01.mol.0000180167.15820.ae. PMID:16148538
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM, Hansson GK. Inflammation in Atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54:2129-38. doi:10.1016/j.jacc.2009.09.009. PMID:19942084
   PubMed Web of Science ®Google Scholar
• Rosa CM, Xavier NP, Henrique Campos D, Fernandes AA, Cezar MD, Martinez PF, Cicogna AC, Gimenes C, Gimenes R, Okoshi MP, et al. Diabetes mellitus activates fetal gene program and intensifies cardiac remodeling and oxidative stress in aged spontaneously hypertensive rats. Cardiovascular Diabetol. 2013;12:152. doi:10.1186/1475-2840-12-152.
   PubMed Web of Science ®Google Scholar
• Tabak O, Gelisgen R, Erman H, Erdenen F, Muderrisoglu C, Aral H, Uzun H. Oxidative lipid, protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus. Clin Invest Med. 2011;34:E163-71. doi:10.25011/cim.v34i3.15189. PMID:21631993
   PubMed Web of Science ®Google Scholar
• Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-20. doi:10.1038/414813a. PMID:11742414
   PubMed Web of Science ®Google Scholar
• Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787-90. doi:10.1038/35008121. PMID:10783895
   PubMed Web of Science ®Google Scholar
• Santos L, Escande C, Denicola A. Potential modulation of Sirtuins by oxidative stress. Oxidative Med Cell Longevity. 2016;2016:9831825. doi:10.1155/2016/9831825.
   PubMed Web of Science ®Google Scholar
• Merksamer PI, Liu Y, He W, Hirschey MD, Chen D, Verdin E. The sirtuins, oxidative stress and aging: an emerging link. Aging (Albany NY). 2013;5:144-50. doi:10.18632/aging.100544. PMID:23474711
   PubMedGoogle Scholar
• Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 2004;303:2011-5. doi:10.1126/science.1094637. PMID:14976264
   PubMed Web of Science ®Google Scholar
• Lee JH, Song MY, Song EK, Kim EK, Moon WS, Han MK, Park JW, Kwon KB, Park BH. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes. 2009;58:344-51. doi:10.2337/db07-1795. PMID:19008341
   PubMed Web of Science ®Google Scholar
• Luo K, Vega-Palas MA, Grunstein M. Rap1-Sir4 binding independent of other Sir, yKu, or histone interactions initiates the assembly of telomeric heterochromatin in yeast. Genes Dev. 2002;16:1528-39. doi:10.1101/gad.988802. PMID:12080091
   PubMed Web of Science ®Google Scholar
• Lieb JD, Liu X, Botstein D, Brown PO. Promoter-specific binding of Rap1 revealed by genome-wide maps of protein-DNA association. Nat Genetics. 2001;28:327-34. doi:10.1038/ng569. PMID:11455386
   PubMed Web of Science ®Google Scholar
• Adamczyk J, Deregowska A, Skoneczny M, Skoneczna A, Kwiatkowska A, Potocki L, Rawska E, Pabian S, Kaplan J, Lewinska A, et al. Adaptive response to chronic mild ethanol stress involves ROS, sirtuins and changes in chromosome dosage in wine yeasts. Oncotarget. 2016;7:29958-76. doi:10.18632/oncotarget.8673. PMID:27074556
   PubMed Web of Science ®Google Scholar
• Salpea KD, Talmud PJ, Cooper JA, Maubaret CG, Stephens JW, Abelak K, Humphries SE. Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis. 2010;209:42-50. doi:10.1016/j.atherosclerosis.2009.09.070. PMID:19889414
   PubMed Web of Science ®Google Scholar
• Swanson MJ, Baribault ME, Israel JN, Bae NS. Telomere protein RAP1 levels are affected by cellular aging and oxidative stress. Biomedical Reports. 2016;5:181-7. doi:10.3892/br.2016.707. PMID:27446538
   PubMed Web of Science ®Google Scholar
• Berglund K, Reynolds CA, Ploner A, Gerritsen L, Hovatta I, Pedersen NL, Hägg S. Longitudinal decline of leukocyte telomere length in old age and the association with sex and genetic risk. Aging (Albany NY). 2016;8:1398-407. doi:10.18632/aging.100995. PMID:27391763
   PubMedGoogle Scholar
• Wulaningsih W, Watkins J, Matsuguchi T, Hardy R. Investigating the associations between adiposity, life course overweight trajectories, and telomere length. Aging (Albany NY). 2016;8:2689-701. doi:10.18632/aging.101036. PMID:27650676
   PubMedGoogle Scholar
• Peng H, Zhu Y, Yeh F, Cole SA, Best LG, Lin J, Blackburn E, Devereux RB, Roman MJ, Lee ET, et al. Impact of biological aging on arterial aging in American Indians: findings from the Strong Heart Family Study. Aging (Albany NY). 2016;8:1583-92. doi:10.18632/aging.101013. PMID:27540694
   PubMedGoogle Scholar
• De Vusser K, Pieters N, Janssen B, Lerut E, Kuypers D, Jochmans I, Monbaliu D, Pirenne J, Nawrot T, Naesens M. Telomere length, cardiovascular risk and arteriosclerosis in human kidneys: an observational cohort study. Aging (Albany NY). 2015;7:766-75. doi:10.18632/aging.100814. PMID:26539975
   PubMedGoogle Scholar
• Zhao MX, Zhou B, Ling L, Xiong XQ, Zhang F, Chen Q, Li YH, Kang YM, Zhu GQ. Salusin-beta contributes to oxidative stress and inflammation in diabetic cardiomyopathy. Cell Death Dis. 2017;8(3), e2690 doi:10.1038/cddis.2017.106. PMID:28333148
   PubMed Web of Science ®Google Scholar
• Zhang B, Shen Q, Chen Y, Pan R, Kuang S, Liu G, Sun G, Sun X. Myricitrin Alleviates Oxidative Stress-induced Inflammation and Apoptosis and Protects Mice against Diabetic Cardiomyopathy. Sci Rep. 2017;7, 44239 doi:10.1038/srep44239. PMID:28287141
   PubMed Web of Science ®Google Scholar
• Prakoso D, DeBlasio MJ, Qin C, Rosli S, Kiriazis H, Qian H, Du XJ, Weeks KL, Gregorevic P, McMullen JR, Ritchie, RH. Phosphoinositide 3-Kinase (p110alpha) gene delivery Limits Diabetes-induced Cardiac NADPH oxidase and cardiomyopathy in a mouse model with established Diastolic Dysfunction. Clin Sci (Lond). 2017;131:1345-60. doi:10.1042/CS20170063. PMID:28487469
   PubMed Web of Science ®Google Scholar
• Chang AC, Ong SG, LaGory EL, Kraft PE, Giaccia AJ, Wu JC, Blau HM. Telomere shortening and metabolic compromise underlie dystrophic cardiomyopathy. Proc Natl Acad Sci U S A. 2016;113:13120-25. doi:10.1073/pnas.1615340113. PMID:27799523
   PubMed Web of Science ®Google Scholar
• Gordon JW, Shaw JA, Kirshenbaum LA. Multiple facets of NF-kappaB in the heart: to be or not to NF-kappaB. Circulation Res. 2011;108:1122-32. doi:10.1161/CIRCRESAHA.110.226928. PMID:21527742
   PubMed Web of Science ®Google Scholar
• Kim JW, Jin YC, Kim YM, Rhie S, Kim HJ, Seo HG, Lee JH, Ha YL, Chang KC. Daidzein administration in vivo reduces myocardial injury in a rat ischemia/reperfusion model by inhibiting NF-kappaB activation. Life Sci. 2009;84:227-34. doi:10.1016/j.lfs.2008.12.005. PMID:19109981
   PubMed Web of Science ®Google Scholar
• Ravingerova T, Adameova A, Carnicka S, Nemcekova M, Kelly T, Matejikova J, Galatou E, Barlaka E, Lazou A. The role of PPAR in myocardial response to ischemia in normal and diseased heart. Gen Physiol Biophys. 2011;30:329-41. doi:10.4149/gpb_2011_04_329. PMID:22131314
   PubMed Web of Science ®Google Scholar
• Kolwicz SC, Purohit S, Tian R. Cardiac metabolism and its interactions with contraction, growth, and survival of the cardiomyocte. Circulation Res. 2013;113:603-16. doi:10.1161/CIRCRESAHA.113.302095. PMID:23948585
   PubMed Web of Science ®Google Scholar